Press release Communiqué de presse

Share the news     Partagez les nouvelles

Email Facebook LinkedIn Twitter

Press release Communiqué de presse

March 13, 2001 13 March, 2001

Pheromone Sciences Initiates Veterinary Program

Dr. Walter H. Johnson of the University of Guelph to lead Large Animal Breeding Research Effort

Pheromone Sciences Corp (CDNX: PHS), today announced that it has engaged the Ontario Veterinary College to carry out experiments into veterinary applications for its PSC Fertility Monitor(tm). The work will be carried out under the auspices of Dr. Walter H. Johnson DVM, MVSc, Dipl. ACT, Professor of Theriogenology at the University of Guelph. The program will investigate the potential for expanding Pheromone's Fertility Monitor platform technology to new applications such as the prediction of estrus and ovulation of animals. Initial research will focus on large animals in a farm breeding situation.

Unmet needs exist in this area as evidenced by the North American dairy industry where dairy industry researchers estimate that U.S. producers incur revenue losses directly attributable to inefficient herd reproduction management of approx. $400 million per annum. The ability to provide accurate monitoring of the fertility status of commercial livestock would afford a significant commercial opportunity for both the agricultural community and Pheromone Sciences Corp.

"During the coming year we look forward to working through the issues in order to pursue the optimum solution for these important veterinary applications," said Dr. Johnson "A product that can increase conception rates in dairy herd breeding would positively impact productivity on dairy farms across North America. Improvements achieved in dairy herds may also have implications for breeding challenges in other animals"

"Fertility and ovulation monitoring problems are not unique to the dairy industry. Horses, sheep, pigs, small, captive and exotic (zoo) animals face similar breeding problems", said Christopher Neuman, President and CEO of Pheromone Sciences Corp. "Adapting the PSC Fertility Monitor(tm) platform technology to serve the special fertility and ovulation detection breeding needs of these groups represent a vertical opportunity where we can capitalize on the knowledge base already acquired through the monitor's development process for human use."

Pheromone Sciences Corp. is a biotechnology and medical diagnostics device research and development company that focuses on commercializing technologies in the field of human reproduction and sexuality.

Statements contained in this press release, including those pertaining to scientific and clinical research, commercialization plans, strategic alliances, and intellectual property protection, other than statements of historical fact, are forward-looking statements subject to a number of uncertainties that could cause actual results to differ materially from statements made. The Canadian Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the contents of this news release.